Publication: Cloning, expression and characterization of histidine-tagged biotin synthase of Mycobacterium tuberculosis
Issued Date
2016-05-01
Resource Type
ISSN
1873281X
14729792
14729792
Other identifier(s)
2-s2.0-84962612128
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Tuberculosis. Vol.98, (2016), 42-49
Suggested Citation
Clement Chedza Magwamba, Kamolchanok Rukseree, Prasit Palittapongarnpim Cloning, expression and characterization of histidine-tagged biotin synthase of Mycobacterium tuberculosis. Tuberculosis. Vol.98, (2016), 42-49. doi:10.1016/j.tube.2016.02.006 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/40836
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Cloning, expression and characterization of histidine-tagged biotin synthase of Mycobacterium tuberculosis
Abstract
© 2016 Elsevier Ltd. Summary The emergence of Mycobacterium tuberculosis strains that are resistant to the current anti-tuberculosis (TB) drugs necessitates a need to develop a new class of drugs whose targets are different from the current ones. M. tuberculosis biotin synthase (MtbBS) is one such target that is essential for the survival of the bacteria. In this study, MtbBS was cloned, overexpressed and purified to homogeneity for biochemical characterization. It is likely to be a dimer in its native form. Its pH and temperature optima are 8.0 and 37 °C, respectively. Kmfor DTB and SAM was 2.81 ± 0.35 and 9.95 ± 0.98 μM, respectively. The enzyme had a maximum velocity of 0.575 ± 0.015 μM min-1, and a turn-over of 0.0935 min-1. 5′-deoxyadenosine (dAH), S-(5′-Adenosyl)-l-cysteine (AdoCy) and S-(5′-Adenosyl)-l-homocysteine (AdoHcy) were competitive inhibitors of MtbBS with the following inactivation parameters: Ki= 24.2 μM, IC50= 267.4 μM; Ki= 0.84 μM, IC50= 9.28 μM; and Ki= 0.592 μM, IC50= 6.54 μM for dAH, AdoCy and AdoHcy respectively. dAH could inhibit the growth of M. tuberculosis H37Ra with an MIC of 392.6 μg/ml. This information should be useful for the discovery of inhibitors of MtbBS.